Comprehensive Analysis of Immune Cell Infiltration and M2-Like Macrophage Biomarker Expression Patterns in Atrial Fibrillation

被引:0
作者
Yang, Man [1 ,3 ]
Xu, Xiang [4 ,5 ]
Zhao, Xing-an [1 ,2 ]
Ge, Yun-na [1 ,2 ]
Qin, Juan [1 ]
Wang, Xi-ya [1 ,2 ]
Dai, Hua-lei [1 ]
Jia, Ji [1 ]
Tao, Si-ming [1 ]
机构
[1] Yunnan Univ, Dept Cardiol, Affiliated Hosp, 76 Youth Rd, Kunming 650021, Yunnan, Peoples R China
[2] Dali Univ, Sch Med, Dali, Yunnan, Peoples R China
[3] First Peoples Hosp Dali, Dept Cardiol, Dali, Yunnan, Peoples R China
[4] Yunnan Univ, Sch Med, Kunming, Yunnan, Peoples R China
[5] Kunming Med Univ, Affiliated Hosp 2, Dept Cardiol, Kunming, Yunnan, Peoples R China
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2024年 / 17卷
关键词
atrial fibrillation; M2; macrophage; cardiac fibrosis; inflammation; single-cell RNA-sequencing; bulk RNA-sequencing; INFLAMMATION; ASSOCIATION; INHIBITION; FIBROSIS; RECEPTOR;
D O I
10.2147/IJGM.S462895
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Macrophages play a crucial role in the progression of AF, closely linked to atrial inflammation and myocardial fibrosis. However, the functions and molecular mechanisms of different phenotypic macrophages in AF are not well understood. This study aims to analyze the infiltration characteristics of atrial immune cells in AF patients and further explore the role and molecular expression patterns of M2 macrophage-related genes in AF. Methods: This study integrates single-cell and large-scale sequencing data to analyze immune cell infiltration and molecular characterization of the LAA in patients with AF, using SR as a control group. CIBERSORT assesses immune cell types in LAA tissues; WGCNA identifies signature genes; cell clustering analyzes cell types and subpopulations; cell communication explores macrophage interactions; hdWGCNA identifies M2 macrophage gene modules in AF. AF biomarkers are identified using LASSO and Random Forest, validated with ROC curves and RT-qPCR. Potential molecular mechanisms are inferred through TF-miRNA-mRNA networks and single-gene enrichment analyses. Results: Myeloid cell subsets varied considerably between the AF and SR groups, with a significant increase in M2 macrophages in the AF group. Signals of inflammation and matrix remodeling were observed in AF. M2 macrophage-related genes IGF1, PDK4, RAB13 , and TMEM176B were identified as AF biomarkers, with RAB13 and TMEM176B being novel markers. A TF-miRNA-mRNA network was constructed using target genes, which are enriched in the PPAR signaling pathway and fatty acid metabolism. Conclusion: Over infiltration of M2 macrophages may be an important factor in the progression of AF. The M2 macrophage-related genes IGF1, RAB13, TMEM176B and PDK4 may regulate the progression of AF through the PPAR signaling pathway and fatty acid metabolism.
引用
收藏
页码:3147 / 3169
页数:23
相关论文
共 29 条
  • [21] Complement C1S is a potential prognostic biomarker and associated with M2 macrophage infiltration in gliomas: From bioinformatics to comprehensive experimental validation
    Gao, Lun
    Jing, Xiongfei
    Hua, Qiuwei
    Li, Zhiyang
    Lei, Pan
    Song, Ping
    Zhou, Long
    Tian, Yihao
    Liu, Junhui
    Cai, Qiang
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [22] Prognostic value of FCER1G expression and M2 macrophage infiltration in esophageal squamous cell carcinoma
    Peng, Wei
    Zhao, Yali
    Yang, Ningning
    Fang, Yan
    Wu, Yintong
    Feng, Zhenzhong
    Wu, Qiang
    Wang, Xian
    [J]. DISCOVER ONCOLOGY, 2025, 16 (01)
  • [23] Evaluation of M2-like macrophage enrichment after diffuse traumatic brain injury through transient interleukin-4 expression from engineered mesenchymal stromal cells
    Syed Faaiz Enam
    Sajidur Rahman Kader
    Nicholas Bodkin
    Johnathan G. Lyon
    Mark Calhoun
    Cesar Azrak
    Pooja Munnilal Tiwari
    Daryll Vanover
    Haichen Wang
    Philip J. Santangelo
    Ravi Venkat Bellamkonda
    [J]. Journal of Neuroinflammation, 17
  • [24] Evaluation of M2-like macrophage enrichment after diffuse traumatic brain injury through transient interleukin-4 expression from engineered mesenchymal stromal cells
    Enam, Syed Faaiz
    Kader, Sajidur Rahman
    Bodkin, Nicholas
    Lyon, Johnathan G.
    Calhoun, Mark
    Azrak, Cesar
    Tiwari, Pooja Munnilal
    Vanover, Daryll
    Wang, Haichen
    Santangelo, Philip J.
    Bellamkonda, Ravi Venkat
    [J]. JOURNAL OF NEUROINFLAMMATION, 2020, 17 (01)
  • [25] The emerging role of cell cycle protein p53 expression by tumor cells and M2-macrophage infiltration in urinary bladder cancer
    Aljabery, Firas
    Shabo, Ivan
    Saudi, Aus
    Holmbom, Martin
    Olson, Hans
    Jahnson, Staffan
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (03) : 148.e9 - 148.e16
  • [26] Macrophage M2 Co-expression Factors Correlate With the Immune Microenvironment and Predict Outcome of Renal Clear Cell Carcinoma
    Wang, Yutao
    Yan, Kexin
    Lin, Jiaxing
    Li, Jun
    Bi, Jianbin
    [J]. FRONTIERS IN GENETICS, 2021, 12
  • [27] Systematic Multiomic Analysis of PKHD1L1 Gene Expression and Its Role as a Predicting Biomarker for Immune Cell Infiltration in Skin Cutaneous Melanoma and Lung Adenocarcinoma
    Kang, Ji Young
    Yang, Jisun
    Lee, Haeryung
    Park, Soochul
    Gil, Minchan
    Kim, Kyung Eun
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [28] Six-transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial-mesenchymal
    Wei, Haotian
    Li, Zhaochen
    Zhao, Yang
    Zhu, Shimiao
    Wen, Simeng
    Quan, Changyi
    [J]. CANCER REPORTS, 2023, 6 (08)
  • [29] SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma
    Kong, Pengzhou
    Jiao, Ye
    Sun, Meng
    Zhou, Zhinan
    Zhang, Yingying
    Yang, Xin
    Ren, Jing
    Yang, Mengyuan
    Dong, Yanyan
    Song, Bin
    [J]. FRONTIERS IN IMMUNOLOGY, 2025, 16